Recent studies had revealed that AIM2 enhanced the stability of Treg cells by attenuating AKT phosphorylation, mTOR and MYC signaling, and glycolysis, while promoting lipid oxidative phosphorylation, thereby ameliorating autoimmune diseases (32). The gene discussed is AKT1; the disease is autoimmune disease.